| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |